Bioxcel Therapeutics Financial Overview
Bioxcel Therapeutics's market cap is currently $36.54M. The company's EPS TTM is $-2.18; its P/E ratio is -0.15; Bioxcel Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
